ReviewFrontiers in neurology2025

Treatment and prognosis of failure of first-line immunotherapy or recurrent autoimmune encephalitis patients with ofatumumab-a fully human anti-CD20 mAb.

Yajing Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.